Francesca Florio
Metabolic Disease Scientist, Pioneering Medicines

Francesca Florio joined Flagship Pioneering in 2024 as a Metabolic Disease Scientist for Pioneering Medicines. As a member of the Mechanism of Action team, she performs proof of concept studies and supports the drug discovery project teams in target discovery, validation and characterization of novel and emerging drug candidates.
Francesca brings research experience and expertise in skeletal muscle biology, skeletal muscle dysfunction, inflammation, and regeneration. During her Ph.D. research she investigated the role of the immune system in the progression of muscle fibrosis and dystrophy using in vitro and preclinical models.
Francesca received her Ph.D. in Biomolecular Sciences from the University of Trento and her MS in Biotechnology from the University of Bologna, both in Italy. She has contributed to several research publications and through a previous collaboration with the private sector became a co-inventor of a patented method that has the potential to combat muscular dystrophy.
